“Polyomavirus simian virus 40 (SV40) is a known oncogenic DNA virus which induces primary brain and bone cancers, malignant mesothelioma, and lymphomas in laboratory animals.” New studies have revealed that SV40 can cause not only infections but also many serious diseases in humans, including cancer.
According to a meta-analysis conducting on molecular data and clinical pathological of 1,793 cancer patients, SV40 is associated with a considerable risk of many cancers such as brain cancer, bone cancer, malignant mesothelioma, and non-Hodgkin lymphoma. In addition, Experimental data shows significant evidence that SV40 can lead to the occurrence of these cancers in human. “Therefore, the main types of tumors induced by SV40 in laboratory animals are the same as human malignancies containing markers for SV40”, say the scientists.
However, The Center for Disease Control (CDC) admitted that “98 million Americans have been infected for eight years with polio vaccines containing the carcinogenic virus SV40.” The public was kept in ignorance for decades about the contamination of the polio vaccines with the Simian Virus 40 (SV40), and its enormous implications in the rising global cancer epidemic, although the scientific community was well aware of these facts since 1960.
But thanks to prosecution, investigation reports in the 1990s, and a Congressional hearing in 2003, the public has been informed of the extent of contamination and its possible link with a large number of fatal forms of cancer that are still destroying life today. Yet the great majority of people in the public are not aware of the facts, and still promoting the “so-called safety and beneficial effects” of those vaccines.
In the wake of these admissions and inquiries, the CDC issued a fact sheet on its website which relates to the links between many types of cancer, Simian Virus 40 (SV40), and the vaccines against polio: inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV). “The document confirmed the presence of SV40 in about 10 to 30 million doses of polio vaccines. But it also challenged the scientific claims regarding the presence of the virus in cancerous tumors and its possible role in causing cancers.
Even worse, in the late 1990s scientists found that there was a secondary form of this SV40 in polio vaccines manufactured after 1963 but which was not detected by the tests previously done. This could mean that the impact of this virus on the public, though little known, could have been much more extensive than we can possibly imagine.
But from June 2013, the CDC page was apparently removed from their website. It is no longer available except in a version (cached) recovery in a video. It is believed the removal was done so that manufacturers of these vaccines are not responsible for this cruelty. However, pharmaceutical companies continue to produce these vaccines, and they are administered daily to the Americans and people all over the world.
The number of deaths caused by polio vaccine over several decades is not known. Nobody knows exactly how many people have killed by cancers caused by these polio vaccines supposed to “save lives”, considering people in different part of the work receive polio vaccine as recommended by their physician. The number of these people is undoubtedly likely to be several thousand times, far greater than the number of lives that would have allegedly been saved from “polio” without vaccine.
- Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer: Regis A. Vilchez and Janet S. Butel – PMCID: PMC452549
- Polio eradication: a complex end game – BMJ 2012 ; 344 doi : http://dx.doi.org/10.1136/bmj.e2398 (Published 02 April 2012) Cite this as: BMJ 2012;344:e2398
- Shah, K; Nathanson, N (January 1976). “Human exposure to SV40: Review and comment”. American Journal of Epidemiology 103 (1): 1–12.
- Sweet, B. H.; Hilleman, M. R. (November 1960). “The vacuolating virus, S.V. 40″. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 105 (2): 420–427.
- Eddy, B. E.; Borman, G. S.; Grubbs, G. E.; Young, R. D. (May 1962). “Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40″. Virology 17: 65–75.
- Fiers, W; Contreras, R; Haegemann, G; Rogiers, R; Van De Voorde, A; Van Heuverswyn, H; Van Herreweghe, J; Volckaert, G; Ysebaert, M (May 1978). “Complete nucleotide sequence of SV40 DNA”. Nature 273 (5658): 113–20.
- Yamamoto, Hiroshi; Shimojo, H (August 1971). “Multiplicity reactivation of human adenovirus type 12 and simian virus 40 irradiated by ultraviolet light”. Virology 45 (2): 529–31.
- Hall, J. D. (1982). “Repair of psoralen-induced crosslinks in cells multiply infected with SV40″. Molecular & General Genetics 188 (1): 135–8.
- Michod, Richard E.; Bernstein, Harris; Nedelcu, Aurora M. (2008). “Adaptive value of sex in microbial pathogens”. Infection, Genetics and Evolution 8 (3): 267–85.
- Eibl, R. H.; Kleihues, P; Jat, P. S.; Wiestler, O. D. (1994). “A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen”. The American journal of pathology 144 (3): 556–64.
- Poulin, D. L.; Decaprio, J. A. (2006). “Is There a Role for SV40 in Human Cancer?”. Journal of Clinical Oncology 24 (26): 4356–65.
- Lowe, D. B.; Shearer, M. H.; Jumper, C. A.; Kennedy, R. C. (2007). “SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen”. Cellular and Molecular Life Sciences 64 (7–8): 803–14.
- Shah, K. V. (2007). “SV40 and human cancer: A review of recent data”. International Journal of Cancer. Journal International Du Cancer 120 (2): 215–23.
- Moens, U; Van Ghelue, M; Johannessen, M (2007). “Oncogenic potentials of the human polyomavirus regulatory proteins”. Cellular and molecular life sciences : CMLS 64 (13): 1656–78.
- Barbanti-Brodano, G; Sabbioni, S; Martini, F; Negrini, M; Corallini, A; Tognon, M (2004). “Simian virus 40 infection in humans and association with human diseases: results and hypotheses”. Virology 318 (1): 1–9.
- “Studies Find No Evidence That SV40 is Related to Human Cancer”. National Cancer Institute, National Institutes of Health. 23 August 2004.
- Engels, E. A.; Chen, J; Hartge, P; Cerhan, J. R.; Davis, S; Severson, R. K.; Cozen, W; Viscidi, R. P. (2005). “Antibody Responses to Simian Virus 40 T Antigen: A Case-Control Study of Non-Hodgkin Lymphoma”. Cancer Epidemiology Biomarkers & Prevention 14 (2): 521–4.
- Engels, Eric A.; Katki, Hormuzd A.; Nielsen, Nete M.; Winther, Jeanette F.; Hjalgrim, Henrik; Gjerris, Flemming; Rosenberg, Philip S.; Frisch, Morten (2003). “Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated with Simian Virus 40″. JNCI Journal of the National Cancer Institute 95 (7): 532–9.
- Stratton, Kathleen; Almario, Donna A.; McCormick, Marie C., eds. (2002). “Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer”. Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer. The National Academy of Sciences. pp. 19–84.
- Namiki, K; Goodison, S; Porvasnik, S; Allan, R. W.; Iczkowski, K. A.; Urbanek, C; Reyes, L; Sakamoto, N; Rosser, C. J. (1 September 2009). “Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells”. PLoS ONE 4 (9): e6872.
- Kroczynska, B; Cutrone, R; Bocchetta, M; Yang, H; Elmishad, A. G.; Vacek, P; Ramos-Nino, M; Mossman, B. T.; Pass, H. I.; Carbone, M (2006). “Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters”. Proceedings of the National Academy of Sciences of the United States of America 103 (38): 14128–33.
- Pershouse, M. A.; Heivly, S; Girtsman, T (2006). “The role of SV40 in malignant mesothelioma and other human malignancies”. Inhalation toxicology 18 (12): 995–1000.
- Ferber, Dan (2002). “Virology. Monkey virus link to cancer grows stronger”. Science 296 (5570): 1012–1015. Archived from the original on May 10, 2002.
- Baggott, Mary Tim, ed. (2007). Nature, the Physician, and the Family: Selected Writings of Herbert Ratner, M.D. AuthorHouse. pp. xv–xvii. ISBN 978-1-4184-7510-9.
- Bookchin, Debbie; Schumacher, Jim (2004). The Virus and the Vaccine. St. Martin’s Press. pp. 226–28.
- Rizzo, Paola; Di Resta, Ilaria; Powers, Amy; Ratner, Herbert; Carbone, Michele (1999). “Unique Strains of SV40 in Commercial Poliovaccines from 1955 Not Readily Identifiable with Current Testing for SV40 Infection”. Cancer Research 59 (24): 6103–8.
- Martini, F; Corallini, A; Balatti, V; Sabbioni, S; Pancaldi, C; Tognon, M (9 July 2007). “Simian virus 40 in humans”. Infectious agents and cancer 2: 13.
- Bookchin, Debbie (7 July 2004). “Vaccine scandal revives cancer fear”. New Scientist.
- NIH/National Cancer Institute (2004-08-25). “Studies Find No Evidence That Simian Virus 40 Is Related To Human Cancer”. Science Daily.
- Hilleman MR (1998). “Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.”. Dev Biol Stand 94: 183–90.
- Carroll-Pankhurst, C; Engels, EA; Strickler, HD; Goedert, JJ; Wagner, J; Mortimer EA Jr. (Nov 2001). “Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period.”. Br J Cancer 85 (9): 1295–7.